Uterine papillary serous carcinoma: epidemiology, pathogenesis and management.

Current opinion in obstetrics & gynecology

Volumn 22, Issue 1, 2010, Pages 21-29

  Fader, Amanda Nickles ^a   Boruta, David ^a   Olawaiye, Alexander B ^a   Gehrig, Paola A ^a  

^a GREATER BALTIMORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; TAXOID;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANCER STAGING; CYSTADENOCARCINOMA; FEMALE; HUMAN; PATHOLOGY; REVIEW; SURVIVAL; UTERUS CANCER;

ANTIBODIES, MONOCLONAL; CHEMOTHERAPY, ADJUVANT; CYSTADENOCARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TAXOIDS; UTERINE NEOPLASMS;

MLCS; MLOWN;

EID: 77951219075     PISSN: None     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/gco.0b013e328334d8a3     Document Type: Review

References (80)